Cargando…
Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application
The development of siRNA technology has provided new opportunities for gene-specific inhibition and knockdown, as well as new ideas for the treatment of disease. Four siRNA drugs have already been approved for marketing. However, the instability of siRNA in vivo makes systemic delivery ineffective....
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227582/ https://www.ncbi.nlm.nih.gov/pubmed/35745766 http://dx.doi.org/10.3390/pharmaceutics14061193 |